Source: Biomatlante Blog

Biomatlante Blog Expanded autologous MSCs and biomaterials in non-unions: a European clinical trial

Philippe Rosset1,2, Philippe Hernigou3, Florian Gebhard4, Christian Ehrnthaller4, Nicola Baldini5, Enrique Gomez Barrena6, Pierre Layrolle1. 1Lab. Pathophysiology of bone resorption, Inserm U957, Nantes, France; 2Orthopedic and trauma surgery, CHRU Tours, Tours,... read more →The post Expanded autologous MSCs and biomaterials in non-unions: a European clinical trial appeared first on Biomatlante.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Julien Dert's photo - CEO of Biomatlante

CEO

Julien Dert

CEO Approval Rating

89/100

Read more